Dr. Daniel Metcalf

Daniel is a biochemist with a PhD in microbiology (biofilm therapy). He has served the wound care industry for 22 years, and during 20 years at Convatec has supported and developed infection and wound management technologies such as FlexiSeal®, Aquacel® Ag, Aquacel® Ag+ Extra, InnovaMatrix®, and now ConvaNiox™. Holding a number of patents, he has received several international awards of recognition, and published 30+ papers on wound biofilm and wound care technologies. Daniel has recently been appointed as Convatec’s first Medical Science Liaison having previously been R&D Director in their Advanced Wound Care business.